We had an opportunity to catch up with EAN Programme Committee Chair Tony Marson (Liverpool, UK), who talked to us on the topic of the special session he moderated entitled: How to use ‘big data’ and digital technology to improve epilepsy care and patient outcomes.
1. What have we learned from audits about the costs of inadequately coordinated care in epilepsy? (0:04)
2. How can the use of ‘big data’ help neurologists in making point-of-care decisions? (1:54)
3. What are the most useful components of a ‘pathways of care’ approach in epilepsy services? (3:00)
4. What are the major barriers in implementing such approaches? (4:12)
5. Could you tell us a little about the European Brain Council (EBC) Value of Treatment of Epilepsy project? (4:36)
Speaker disclosure: UCB Pharma funded the UK audit discussed in this video interview.
Filmed at the 5th Congress of the European Academy of Neurology (EAN), Oslo, Norway, June 2019.
Share this Video
Related Videos In Epilepsy
Kimford Meador, AAN 2021: Fetal Antiseizure Medication in Pregnant Women with Epilepsy
It was a great pleasure to meet with Kimford Meador (Stanford University, Stanford, CA, USA) to discuss the effects and use of antiseizure medications during pregnancy, in women with epilepsy. The abstract entitled: ‘Fetal Antiseizure Medication Effects on Neuropsychological Outcomes at Age 3 Years in the MONEAD Study’ was presented at the American Academy of […]
Kimford Meador, AAN 2021: Preliminary findings of the MONEAD Study
It was a great pleasure to meet with Kimford Meador (Stanford University, Stanford, CA, USA) to discuss the aims, design and preliminary findings from the MONEAD study, and what these results mean for treatment of epilepsy in pregnant women. The abstract entitled: ‘Fetal Antiseizure Medication Effects on Neuropsychological Outcomes at Age 3 Years in the […]
Michael Sperling, AAN 2021: Post-hoc Analysis of Cenobamate for Uncontrolled Focal Seizures
We were delighted to speak with Michael Sperling (Thomas Jefferson University, Philadelphia, PA, USA) to discuss the recent post-hoc analysis of cenobamate for uncontrolled focal seizures, and its intended place in the treatment landscape for epilepsy. The abstract entitled: ‘Efficacy of Cenobamate for Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study’ […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!